These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14380263)

  • 1. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
    FISCHER R
    Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
    [No Abstract]   [Full Text] [Related]  

  • 2. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy.
    FREDERKING W
    J Nerv Ment Dis; 1955 Mar; 121(3):262-6. PubMed ID: 14381913
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and d-lysergic acid diethylamide (LSD25).
    PENNES HH
    J Nerv Ment Dis; 1954 Feb; 119(2):95-112. PubMed ID: 13163687
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 5. Mescaline and LSD-25 in activation of temporal lobe epilepsy.
    SCHWARZ BE; BICKFORD RG; MULDER DW; ROME HP
    Neurology; 1956 Apr; 6(4):275-80. PubMed ID: 13309607
    [No Abstract]   [Full Text] [Related]  

  • 6. The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel.
    RINALDI F; HIMWICH HE
    J Nerv Ment Dis; 1955 Nov; 122(5):424-32. PubMed ID: 13320138
    [No Abstract]   [Full Text] [Related]  

  • 7. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Variations of the cholinergic activity of the cerebral cortex tissue caused by bulbocapnine, lysergic acid diethylamide and mescaline].
    POLONI A; MAFFEZZONI G
    Sist Nerv; 1952; 4(6):578-81. PubMed ID: 13048791
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man.
    SCHWARZ BE; SEM-JACOBSEN CW; PETERSEN MC
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):579-87. PubMed ID: 13325988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the mechanism of lysergic acid diethylamide. I].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(2-3):129-50. PubMed ID: 13078602
    [No Abstract]   [Full Text] [Related]  

  • 11. On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers.
    BRADLEY PB; ELKES C; ELKES J
    J Physiol; 1953 Aug; 121(2):50P-51P. PubMed ID: 13085360
    [No Abstract]   [Full Text] [Related]  

  • 12. The CNS action of d-lysergic acid diethylamide (L.S.D.-25).
    SMITH R
    Mod Hosp; 1953 Jan; 80(1):106-10. PubMed ID: 13025280
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE LATEST FINDINGS IN THE FIELD OF ERGOT ALKALOIDS].
    HOFMANN A
    Dan Tidsskr Farm; 1963 Aug; 37():181-200. PubMed ID: 14049456
    [No Abstract]   [Full Text] [Related]  

  • 14. THE METABOLITES OF ERGOMETRINE AND LYSERGIC ACID DIETHYLAMIDE IN RAT BILE.
    SLAYTOR MB; WRIGHT SE
    J Med Pharm Chem; 1962 May; 5():483-91. PubMed ID: 14056385
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 16. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
    CURTIS DR
    Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of lysergic acid diethylamide on Betta splendens. I.
    TURNER WJ
    Dis Nerv Syst; 1956 Jun; 17(6):193-7. PubMed ID: 13330611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Body scheme disorders in lysergic acid diethylamide].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611
    [No Abstract]   [Full Text] [Related]  

  • 19. Further observations on the effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    J Ment Sci; 1953 Oct; 99(417):804-8. PubMed ID: 13109462
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical studies of lysergic acid diethylamide.
    ANDERSON EW; RAWNSLEY K
    Monatsschr Psychiatr Neurol; 1954; 128(1-2):38-55. PubMed ID: 13203446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.